Your browser doesn't support javascript.
loading
Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02.
Chen, Huanwen; Kuhn, John; Lamborn, Kathleen R; Abrey, Lauren E; DeAngelis, Lisa M; Lieberman, Frank; Robins, H Ian; Chang, Susan M; Yung, W K Alfred; Drappatz, Jan; Mehta, Minesh P; Levin, Victor A; Aldape, Kenneth; Dancey, Janet E; Wright, John J; Prados, Michael D; Cloughesy, Timothy F; Wen, Patrick Y; Gilbert, Mark R.
Afiliação
  • Chen H; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Kuhn J; Division of Pharmacology, University of Texas, San Antonio, Texas, USA.
  • Lamborn KR; Department of Neurological Surgery, University of California, San Francisco, California, USA.
  • Abrey LE; Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • DeAngelis LM; Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Lieberman F; Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Robins HI; Departments of Medicine, Human Oncology, and Neurology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Chang SM; Department of Neurological Surgery, University of California, San Francisco, California, USA.
  • Yung WKA; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Drappatz J; Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Mehta MP; Department of Radiation Oncology, Miami Cancer Institute, Miami, Florida, USA.
  • Levin VA; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Aldape K; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Dancey JE; Queen's University, Kingston, Ontario, Canada.
  • Wright JJ; Investigational Drug Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Prados MD; Department of Neurological Surgery, University of California, San Francisco, California, USA.
  • Cloughesy TF; Department of Neurology, University of California, Los Angeles, Los Angeles, California, USA.
  • Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Gilbert MR; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Neurooncol Adv ; 2(1): vdaa124, 2020.
Article em En | MEDLINE | ID: mdl-33235994
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article